| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF313-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF762-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF2720-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-69753SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF3909-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB110-60986-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB313-SP | |||
![Pericytes express functional Tie2.(a) Microarray-based expression screening of brain pericytes (BP), placenta pericytes (PP), pancreas pericytes (PA), lung pericytes (LP), muscle pericytes (MP) and human umbilical vein endothelial cells (HUVEC [HU]). (b) Semi-quantitative PCR of TEK (Tie2), endothelial marker genes (PECAM1, CDH5) and pericyte marker genes (CSPG4, CD248) in HUVEC and BP; house keeping gene: GAPDH. (c) Representative images showing expression of Tie2 in HUVEC and BP. (d) Histogram of membrane-bound Tie2 expression in HUVEC and BP compared to isotype control measured by flow cytometry. (e,g) Western blot (WB) analysis of tyrosine phosphorylation (pTyr) and total Tie2 after Tie2 immunoprecipitation (IP) in BP (e) and HUVEC (g) upon stimulation with recombinant human (rh) Ang1 compared to unstimulated (us) cells. (f,h) Quantification of the ratio of phosphorylated Tie2 (pTie2) relative to total Tie2 protein in BP (f) and HUVEC (h) normalized to us control (n=3). (i,k) Western blot analysis of AKT phosphorylation (Ser473) in control (shCtr) and Tie2-silenced (shTie2 I/shTie2 II) BP (i) and HUVEC (k) upon stimulation with rhAng1 or rhAng2. (j,l) Quantification of the ratio of pAKT to total AKT protein expression in BP (j) and HUVEC (l) normalized to unstimulated control (n=3). Representative western blot images are cropped versions and original images can be found in Supplementary Fig. 15. Scale bars: 20 μm (c). Data are shown as mean±s.d. Statistics were performed using Mann–Whitney U test (f,h) and one-way ANOVA (j,l). *P<0.05, **P<0.01. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/28719590), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/af762_mouse-rat-tie-2-affinity-purified-polyclonal-ab-8220249505990.jpg)
![Pericytes express functional Tie2.(a) Microarray-based expression screening of brain pericytes (BP), placenta pericytes (PP), pancreas pericytes (PA), lung pericytes (LP), muscle pericytes (MP) and human umbilical vein endothelial cells (HUVEC [HU]). (b) Semi-quantitative PCR of TEK (Tie2), endothelial marker genes (PECAM1, CDH5) and pericyte marker genes (CSPG4, CD248) in HUVEC and BP; house keeping gene: GAPDH. (c) Representative images showing expression of Tie2 in HUVEC and BP. (d) Histogram of membrane-bound Tie2 expression in HUVEC and BP compared to isotype control measured by flow cytometry. (e,g) Western blot (WB) analysis of tyrosine phosphorylation (pTyr) and total Tie2 after Tie2 immunoprecipitation (IP) in BP (e) and HUVEC (g) upon stimulation with recombinant human (rh) Ang1 compared to unstimulated (us) cells. (f,h) Quantification of the ratio of phosphorylated Tie2 (pTie2) relative to total Tie2 protein in BP (f) and HUVEC (h) normalized to us control (n=3). (i,k) Western blot analysis of AKT phosphorylation (Ser473) in control (shCtr) and Tie2-silenced (shTie2 I/shTie2 II) BP (i) and HUVEC (k) upon stimulation with rhAng1 or rhAng2. (j,l) Quantification of the ratio of pAKT to total AKT protein expression in BP (j) and HUVEC (l) normalized to unstimulated control (n=3). Representative western blot images are cropped versions and original images can be found in Supplementary Fig. 15. Scale bars: 20 μm (c). Data are shown as mean±s.d. Statistics were performed using Mann–Whitney U test (f,h) and one-way ANOVA (j,l). *P<0.05, **P<0.01. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/28719590), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/af762_mouse-rat-tie-2-affinity-purified-polyclonal-ab-4420241543319.jpg)
![N/A Tie-2 [Biotin]](http://images.novusbio.com/fullsize2/DATA_Tie2_DY5159_ELISA_2083.jpg "N/A Tie-2 [Biotin]")
![Western Blot: Tie-2 Antibody [NBP1-69753] - Total protein from human Huvec cells and mouse stomach tissue was separated on a 7.5% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 1.0 ug/ml anti-TIE2 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.](http://images.novusbio.com/fullsize/Tie-2-Antibody-Western-Blot-NBP1-69753-img0006.jpg "Western Blot: Tie-2 Antibody [NBP1-69753] - Total protein from human Huvec cells and mouse stomach tissue was separated on a 7.5% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 1.0 ug/ml anti-TIE2 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.")
![Immunohistochemistry-Paraffin: Tie-2 Antibody [NBP1-69753] - Analysis of a FFPE tissue section of mouse stomach using 1:200 dilution of Tie-2 antibody (NBP1-69753). The staining was developed using HRP labeled anti-rabbit secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin.](http://images.novusbio.com/fullsize/Tie-2-Antibody-Immunohistochemistry-Paraffin-NBP1-69753-img0007.jpg)
![Western Blot: Tie-2 Antibody [NBP1-69753] - Detection of TIE2 in Huvec cell lysate](http://images.novusbio.com/fullsize/Tie-2-Antibody-Western-Blot-NBP1-69753-img0003.jpg)
![Simple Western: Tie-2 Antibody [NBP1-69753] - Simple Western lane view shows a specific band for Tie-2 in 0.5 mg/ml of HUVEC lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.](http://images.novusbio.com/fullsize/Tie-2-Antibody-Simple-Western-NBP1-69753-img0005.jpg)
![N/A Tie-2 [HRP]](http://images.novusbio.com/fullsize2/DATA_Tie2_MTE200_ELISA_1038.jpg "N/A Tie-2 [HRP]")
![N/A Tie-2 [HRP]](http://images.novusbio.com/fullsize2/Tie-2_MTE200_ELISA_326.jpg)
![Western Blot: Tie-2 Antibody (MM0018-21G7) - Azide and BSA Free [NB110-60986] - Effects of proteasome inhibitor ALLN (dose-dependent) on the vascular receptor protein expression in HUVECs.](http://images.novusbio.com/fullsize/Tie-2-Antibody-MM0018-21G7-Azide-and-BSA-Free-Western-Blot-NB110-60986-img0008.jpg "Western Blot: Tie-2 Antibody (MM0018-21G7) - Azide and BSA Free [NB110-60986] - Effects of proteasome inhibitor ALLN (dose-dependent) on the vascular receptor protein expression in HUVECs.")
![Immunohistochemistry: Tie-2 Antibody (MM0018-21G7) - Azide and BSA Free [NB110-60986] - Formalin fixed and paraffin embedded human placental tissue section is subjected to IHC with anti human Tie-2.](http://images.novusbio.com/fullsize/Tie-2-Antibody-MM0018-21G7-Azide-and-BSA-Free-Immunohistochemistry-NB110-60986-img0007.jpg)
![Immunohistochemistry-Paraffin: Tie-2 Antibody (MM0018-21G7) [NB110-60986] - Human lymph node. Tissue section pre-treated with proteinase K for 5 minutes at 37C. Antibody at 1:50. Detection with tyramide amplification system (DAKO CSA II). IHC-P image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Tie-2-Antibody-MM0018-21G7-Immunohistochemistry-Paraffin-NB110-60986-img0005.jpg)
![Immunohistochemistry: Tie-2 Antibody (MM0018-21G7) - Azide and BSA Free [NB110-60986] - Formalin fixed and paraffin embedded human placental tissue section is subjected to IHC with anti human Tie-2.](http://images.novusbio.com/fullsize/Tie-2-Antibody-MM0018-21G7-Azide-and-BSA-Free-Immunohistochemistry-NB110-60986-img0006.jpg)